Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Technical risks with subcutaneous insulin infusion.

I Guilhem1, A M Leguerrier, F Lecordier

  • 1Unité de Diabétologie, CHU de Rennes, France. isabelle.guilhem@chu-rennes.fr

Diabetes & Metabolism
|June 27, 2006
PubMed
Summary

Continuous subcutaneous insulin infusion (CSII) is increasingly popular for diabetes management. While technical issues like infusion set obstruction can occur, pump malfunctions are less common, suggesting improvements in CSII therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practical implementation of automated insulin delivery systems in 2025: A French position statement update.

Diabetes & metabolism·2025
Same author

Practical implementation of automated closed-loop insulin delivery: A French position statement.

Diabetes & metabolism·2020
Same author

Eating behaviours associated with glycaemic variability and fear of hypoglycaemia in adults with type 1 diabetes.

Diabetes & metabolism·2019
Same author

Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement.

Diabetes & metabolism·2017
Same author

Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51-Case Cohort Study.

World journal of surgery·2017
Same author

Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.

European journal of endocrinology·2015

Area of Science:

  • Endocrinology
  • Medical Devices
  • Diabetes Mellitus Management

Background:

  • Continuous subcutaneous insulin infusion (CSII) has gained popularity for achieving strict glycemic control in diabetic patients.
  • Historical reports (1980s) focused on technical faults like ketoacidosis, often due to infusion set obstruction or site infections.
  • Limited data exists on insulin pump failures themselves.

Purpose of the Study:

  • To report on insulin pump malfunctions in patients using CSII therapy.
  • To analyze pump failures recorded between 2001 and 2004.
  • To provide insights into the technical risks associated with CSII.

Main Methods:

  • Retrospective analysis of pump malfunctions.
  • Data collected from 376 pumps used in CSII therapy in Brittany between 2001 and 2004.

Related Experiment Videos

  • Review of reported technical events and patient outcomes.

    • Main Results:

    • Insulin pump malfunctions were recorded during the study period.
    • Obstruction of infusion sets and infection at the infusion site remain frequent issues.
    • Recent studies show a decrease in metabolic complications, potentially due to technical advancements and improved physician/patient education.

    Conclusions:

    • While CSII therapy has seen improvements leading to fewer complications, ongoing monitoring and education are crucial.
    • Further clinical studies are needed to reassess the technical risks associated with newer CSII devices.
    • Formal educational programs for CSII users should include instructions for monitoring insulin pump therapy.